Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2) (N-Term) Peptid
Kurzübersicht für Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2) (N-Term) Peptid (ABIN8104339)
Target
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- LZTS2 Peptide - N-terminal region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-LZTS2 antibody ( ARP58817_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Hintergrund
-
Background Information: LZTS2 is a negative regulator of katanin-mediated microtubule severing and release from the centrosome. LZTS2 is required for central spindle formation and the completion of cytokinesis. LZTS2 may negatively regulate axonal outgrowth by preventing the for
Alternative Symbols: KIAA1813, LAPSER1, RP11-108L7.8
-
Molekulargewicht
- 73kDa
-
Gen-ID
- 84445
-
NCBI Accession
- NP_115805
-
UniProt
- Q9BRK4
Target
-